Arnaud Tarantola

Dr. Arnaud Tarantola

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
VDVeasna Duong
Veasna Duong
LLLouis Lambrechts
Louis Lambrechts
Richard PaulRichard Paul
Richard Paul
SLSowath Ly
Sowath Ly
RLRath Srey Lay
Rath Srey Lay
PBPhilippe Buchy
Philippe Buchy
Significance: Our work provides evidence that people who are infected with dengue virus without developing detectable clinical symptoms or prior to the onset of symptoms are infectious to mosquitoes. At a given level of viremia, symptom-free people were markedly more infectious to mosquitoes than clinically symptomatic patients. Our results fundamentally change the current paradigm for dengue epidemiology and control, based on detection of dengue virus-infected cases with apparent illness.

20 August 2009 in Eurosurveillance
Verified
Journal Article
Open access
LVL Vaillant
L Vaillant
GRG La Ruche
G La Ruche
ATArnaud Tarantola
Arnaud Tarantola
PBP Barboza
P Barboza
FIfor the epidemic intelligence team at InVS
for the epidemic intelligence team at InVS
This article describes the characteristics of 574 deaths associated with pandemic H1N1 influenza up to 16 July 2009. Data (except from Canada and Australia) suggest that the elderly may to some extent be protected from infection. There was underlying disease in at least half of the fatal cases. Two risk factors seem of particular importance: pregnancy and metabolic condition (including obesity which has not been considered as risk factor in previous pandemics or seasonal influenza).

1 August 2006 in American Journal of Infection Control
Verified
Journal Article
Closed access
ATArnaud Tarantola
Arnaud Tarantola
DADominique Abiteboul
Dominique Abiteboul
ARAnne Rachline
Anne Rachline

15 January 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MNMaya Nadimpalli
Maya Nadimpalli
EDElisabeth Delarocque-Astagneau
Elisabeth Delarocque-Astagneau
DLDavid C Love
David C Love
LPLance B Price
Lance B Price
BHBich-Tram Huynh
Bich-Tram Huynh
AAArmiya Youssouf Abdou
Armiya Youssouf Abdou
Antibiotic misuse in lower- and middle-income countries (LMICs) contributes to the development of antibiotic resistance that can disseminate globally. Strategies specific to LMICs that seek to reduce antibiotic misuse by humans, but simultaneously improve antibiotic access, have been proposed. However, most approaches to date have not considered the growing impact of animal and environmental reservoirs of antibiotic resistance, which threaten to exacerbate the antibiotic resistance crisis in LMICs. In particular, current strategies do not prioritize the impacts of increased antibiotic use for terrestrial food-animal and aquaculture production, inadequate food safety, and widespread environmental pollution. Here, we propose new approaches that address emerging, One Health challenges.

1 April 2009 in Emerging Infectious Diseases
Verified
Journal Article
Open access
DSDaouda Sissoko
Daouda Sissoko
CGClaude Giry
Claude Giry
PGPhilippe Gabrie
Philippe Gabrie
ATArnaud Tarantola
Arnaud Tarantola
FPFrançois Pettinelli
François Pettinelli
VPVincent Pierre
Vincent Pierre
After the 2006–2007 epidemic wave of Rift Valley fever (RVF) in East Africa and its circulation in the Comoros, laboratory case-finding of RVF was conducted in Mayotte from September 2007 through May 2008. Ten recent human RVF cases were detected, which confirms the indigenous transmission of RFV virus in Mayotte.

15 November 2005 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
YYY. Yazdanpanah
Y. Yazdanpanah
GCGabriella De Carli
Gabriella De Carli
BMB. Migueres
B. Migueres
FLF. Lot
F. Lot
MCM. Campins
M. Campins
EBE. Bouvet
E. Bouvet
Background. Additional studies are required to identify risk factors for hepatitis C virus (HCV) transmission to health care workers after occupation